On April 22, 2026, CCC convened a congressional briefing on kratom and 7-hydroxymitragynine (7-OH) regulation, co-hosted with the Reason Foundation and the Cato Institute. The event drew a strong cross-section of two dozen Member office staffers and public policy advocates working on drug policy and consumer access issues. The panel paired policy and scientific expertise: Yaël Ossowski… Source
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.